Back to STATE STREET CORP STATE STREET CORP

ACRVACRV
14 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in ACRIVON THERAPEUTICS INC

Yes. State Street holds 67,145 shares of ACRV (Acrivon Therapeutics), worth $119,518, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. State Street has held ACRV since Q1 2023, across 14 quarterly 13F filings.

Current Value

$119,518

Current Shares

67,145

Total Value Change

-$963,434

Total Shares Change

-18,194

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
67,145
0.0%
$119,5180.0%$1.78
0
2026-Q1
Unchanged
67,145
0.0%
$93,3320.0%$1.39
0
2025-Q4
Unchanged
67,145
0.0%
$161,8190.0%$2.41
0
2025-Q3
Unchanged
67,145
0.0%
$121,5320.0%$1.81
0
2025-Q2
Decreased
67,145
-71.1%
$79,9030.0%$1.19
0
2025-Q1
Decreased
232,551
-1.7%
$472,0790.0%$2.03
0
2024-Q4
Increased
236,601
+4.7%
$1.4M0.0%$6.02
27
2024-Q3
Increased
225,896
+26.4%
$1.6M0.0%$7.00
32
2024-Q2
Increased
178,663
+34.0%
$1M0.0%$5.80
22
2024-Q1
Unchanged
133,276
0.0%
$952,9230.0%$7.15
0
2023-Q4
Unchanged
133,276
0.0%
$655,7180.0%$4.92
0
2023-Q3
Increased
133,276
+5.8%
$1.3M0.0%$9.56
27
2023-Q2
Increased
125,976
+47.6%
$1.6M0.0%$12.96
35
2023-Q1
New
85,339
-
$1.1M0.0%$12.69
35

Other major holders of ACRV: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used